ASCO
In a note to investors last Tuesday, investment banking firm Dawson James initiated coverage on shares of Immunocellular Therapeutics Ltd. (NASDAQ: IMUC). Here are some highlights from the report:
Initiating Coverage with a Buy Rating and P... Read the rest of this entry »